ClinicalTrials.gov
public full text
Public Domain
Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients
The purpose of this study is to determine the safety and efficacy of intravenous administration of intermittent doses of levosimendan (infusions of 0,2 μg/kg/min, of levosimendan or placebo, without bolus, for 6 hours every 2 weeks) compared to placebo in ambulatory patients with advanced chronic heart failure.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Levosimendan In Ambulatory Heart Failure Patients#801324
- Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure#835867
- The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement#864981
- Pharmacokinetics of Inhaled Levosimendan#1111749
- Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure#1171946
Record · ID 833229
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive